Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 20

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 20
---
Partnership fails to operate profitably and to generate sufficient cash from operations (and the operations of its subsidiaries), we may
not be able to pay dividends on the Series B Preferred Stock. Furthermore, any new shares of preferred stock senior to or on parity
with the Series B Preferred Stock and Series A Preferred Stock will substantially increase the cash required to continue to
pay cash dividends at stated levels. Any common stock or preferred stock that may be issued in the future to finance acquisitions, upon
exercise of stock options or otherwise, would have a similar effect.

Our ability to pay dividends is limited by the requirements of Maryland law.

Our ability to pay dividends on our Series B
Preferred Stock is limited by Maryland law. Under applicable Maryland law, a Maryland corporation generally may not make a distribution
if, after giving effect to the distribution, the corporation would not be able to pay its debts as the debts become due in the usual course
of business, or the corporation’s total assets would be less than the sum of its total liabilities plus, unless the charter provides
otherwise, the amount that would be needed, if the company were dissolved at the time of the distribution, to satisfy the preferential
rights upon dissolution of stockholders whose preferential rights are superior to those receiving the distribution. Accordingly, we generally
may not make a distribution on our Series B Preferred Stock if, after giving effect to the distribution, we would not be able to
pay our debts as they become due in the usual course of business or our total assets would be less than the sum of our total liabilities
plus, the amount that would be needed to satisfy the preferential rights upon dissolution of the holders of shares of any class or series
of preferred stock of capital stock then outstanding, if any, with preference senior to those of our Series B Preferred Stock, unless
the terms of such class or series provide otherwise.

<div align='center'>S-11</div>

Investors should not expect us to redeem the Series B Preferred Stock on or after the date it becomes redeemable at our option.

The Series B Preferred Stock will be a perpetual
equity security. This means that it will have no maturity or mandatory redemption date and will not be redeemable at the option of the
holders. The Series B Preferred Stock may be redeemed by us at our option either in whole or in part, from time to time, at any time
on or after November 20, 2030. Any decision we may make to propose a redemption of the Series